Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takaji Wakita

Showing results (1-10 of 441) with videos related to

Pageof 45
Sort By:
Cold Spring Harbor Perspectives in Medicine|September 11, 2019
Cell Culture Systems of HCV Using JFH-1 and Other StrainsTakaji Wakita
Advanced Drug Delivery Reviews|October 2, 2007
HCV research and anti-HCV drug discovery: toward the next generationTakaji Wakita
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2008
Isolation of JFH-1 strain and development of an HCV infection systemTakaji Wakita
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 23, 2008
[Hepatitis C virus vaccine]Takaji Wakita
Uirusu|March 25, 2006
[Production of infectious hepatitis C virus in cell culture]Takanobu Kato, Takaji Wakita
Global Health & Medicine|May 4, 2026
From fragmentation to integration: Can Japan's JIHS deliver a resilient system to deal with health emergencies?Norihiro Kokudo, Takaji Wakita
Cold Spring Harbor Perspectives in Medicine|August 5, 2015
Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue TropismKoichi Watashi, Takaji Wakita
Cold Spring Harbor Perspectives in Medicine|May 9, 2018
Small Animal Models of Hepatitis E Virus InfectionTian-Cheng Li, Takaji Wakita
Journal of Virology|March 2, 2012
Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infectionMinetaro Arita, Takaji Wakita, Hiroyuki Shimizu
The Journal of General Virology|September 18, 2008
Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivityMinetaro Arita, Takaji Wakita, Hiroyuki Shimizu
Pageof 45

Showing results (1-10 of 441) with videos related to

Sort By:
Pageof 45
Cold Spring Harbor Perspectives in Medicine|September 11, 2019
Cell Culture Systems of HCV Using JFH-1 and Other StrainsTakaji Wakita
Advanced Drug Delivery Reviews|October 2, 2007
HCV research and anti-HCV drug discovery: toward the next generationTakaji Wakita
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2008
Isolation of JFH-1 strain and development of an HCV infection systemTakaji Wakita
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 23, 2008
[Hepatitis C virus vaccine]Takaji Wakita
Uirusu|March 25, 2006
[Production of infectious hepatitis C virus in cell culture]Takanobu Kato, Takaji Wakita
Global Health & Medicine|May 4, 2026
From fragmentation to integration: Can Japan's JIHS deliver a resilient system to deal with health emergencies?Norihiro Kokudo, Takaji Wakita
Cold Spring Harbor Perspectives in Medicine|August 5, 2015
Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue TropismKoichi Watashi, Takaji Wakita
Cold Spring Harbor Perspectives in Medicine|May 9, 2018
Small Animal Models of Hepatitis E Virus InfectionTian-Cheng Li, Takaji Wakita
Journal of Virology|March 2, 2012
Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infectionMinetaro Arita, Takaji Wakita, Hiroyuki Shimizu
The Journal of General Virology|September 18, 2008
Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivityMinetaro Arita, Takaji Wakita, Hiroyuki Shimizu
Pageof 45